switching glp 1 agonists Weight-loss injections such as GLP-1 agonists (including semaglutide and tirzepatide) Switching GLP1 Medications Is Common

Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation

Thats because Mounjaro has a dual-action that activates GIP & GLP-1 receptors agonist, often described at dual-hormone injection

Blocking this pathway could be a promising therapeutic strategy for DPN by curbing the inflammatory response and potentially preventing further nerve damage [76]

13 Further research is needed to investigate the interconnected pathophysiologic roles of glucagon, GLP-1, and GIP while determining the niche for twincretin therapy in T2DM

Cardiovascular exercise supports calorie expenditure and cardiovascular health

These categories included genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication [2]